PAVmed Inc. (NASDAQ:PAVM – Get Free Report) shares passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $0.73 and traded as low as $0.64. PAVmed shares last traded at $0.66, with a volume of 71,996 shares traded.
Wall Street Analyst Weigh In
Separately, Ascendiant Capital Markets decreased their price objective on PAVmed from $21.00 to $19.00 and set a “buy” rating for the company in a report on Monday, December 9th.
Check Out Our Latest Report on PAVmed
PAVmed Stock Down 0.7 %
About PAVmed
PAVmed Inc focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck.
Read More
- Five stocks we like better than PAVmed
- The Most Important Warren Buffett Stock for Investors: His Own
- 3 Stocks to Gain From Trump’s Return-to-Office Mandate
- Short Selling – The Pros and Cons
- Crane Stock Soars, But the Best Could Be Yet to Come: Here’s Why
- What is the Dogs of the Dow Strategy? Overview and Examples
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
Receive News & Ratings for PAVmed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PAVmed and related companies with MarketBeat.com's FREE daily email newsletter.
